Group items tagged

Discussing the Creation of Revenue Streams from Innovation and Technology - the unofficial blog of GrowthRoute Ventures, the independent consulting company founded by Greg Boutin to serve innovation-based ventures. Includes info on entrepreneurship, government programs, commercialization and funding for ventures.

The Ontario BioAuto Council Investment Fund is a $5-million fund that targets commercialization and market development of biomaterials destined for Ontario's automotive sector.

The Ontario BioAuto Council Investment Fund is a $5-million fund that targets commercialization and market development of biomaterials destined for Ontario's automotive sector.

Clean Tech Funding\n\nIf you have a new, innovative technology that helps address climate change or promotes clean water, land or air, then Sustainable Development Technology Canada (SDTC) wants to hear from you.(\n\nSDTC supports late-stage development and pre-commercial demonstration of clean technologies by Canadian companies.( (The Statement of Interest (SOI) is an initial application used for preliminary screening and is subject to a competitive review process by SDTC and a panel of independent experts. ( (Applications are evaluated on the basis of their fit with SDTC's mandate, selection criteria, and the quality of technology, marketing and business capabilities. ( (IMPORTANT - Prior to submitting an application and to ensure a good fit:\n\n 1. First review the "Application Advice" section and subsections on SDTC's web site, starting at http://www.sdtc.ca/en/funding/advice/index.htm.\n 2. Register for one of their free online webinars or workshop to learn more - see http://sdtc.ca/en/news/events/200803-61120.htm for details. \n 3. Then discuss your proposed project with one of their Applications Managers.\n

MaRS celebrates its first anniversary. Judy Steed, Toronto Star Reporter, caputures some of the people, ideas and developments in commercializing leading edge research at the MaRS Centre.

MaRS celebrates its first anniversary. Judy Steed, Toronto Star Reporter, caputures some of the people, ideas and developments in commercializing leading edge research at the MaRS Centre. Sept 26, 2006

As a site of the Kauffman Foundation, this portal provides links to entrepreneurship and technology commercialization publications including 742 journals, 197 books, 70 reports, 73 conferences, and 116 working-papers. All publications are summarized via free access to their abstract, however access to their full-text depends entirely on their publisher/vendor: some are free, some are pay per view, and some require paid subscription. The portal provides direct linking to full-text if available. Since the portal operates on strict headings, it provides excellent access to publications. Since it links to several citation softwares, it is an excellent resource for those looking to compile lists of references. Otherwise, it is an excellent resource for entrepreneurs wanting to keep up with entrepreneurial research and findings, as well as for those wanting to publish entrepreneurial written work. For an example of what can be found on the portal, download the full text version of "The Entrepreneurial Spawing of Scientists and Engineers: Stars, Slugs, and the Small Firm Effect".

Peter Singer, National Post looks at how we open the innovative sectors of our economy to the global markets and how Canada can assist developing countries to accelerate the commercialization of their own products to tackle their own problems. The MaRS Centre is helping to tackle these problems by bringing together science, business and capital.

Peter Singer, National Post looks at how we open the innovative sectors of our economy to the global markets and how Canada can assist developing countries to accelerate the commercialization of their own products to tackle their own problems. The MaRS Centre is helping to tackle these problems by bringing together science, business and capital. Nov 21, 2007

MaRS helps entrepreneurs to commercialize innovations.

MaRS helps entrepreneurs to commercialize innovations. Feb 8, 2007

Judy Steed, Reporter, The Star, reports about MaRS's first anniversary and talks about the MaRS story where extraordinary developments are commercialized into lead edge research.

Judy Steed, Reporter, The Star, reports about MaRS's first anniversary and talks about the MaRS story where extraordinary developments are commercialized into lead edge research. Feb 8, 2008

Biotechnologies au Canada: l'exemple de l'Ontario in Industrie Pharmaceutique, May 22, 2009 mentions that MaRS Discovery District is an Innovation Centre and mentions how it helps entrepreneurs to commercialize their research.

As stated in Burrill Canadian Biotech News, "MaRS Discovery District and Canadian Stem Cell Network have entered into a partnership agreement to pursue long-term public or private financing for the translational development activities currently being undertaken by Aggregate Therapeutics."

As stated in Burrill Canadian Biotech News, "MaRS Discovery District and Canadian Stem Cell Network have entered into a partnership agreement to pursue long-term public or private financing for the translational development activities currently being undertaken by Aggregate Therapeutics."

Canada is becoming an urban nation. Mention of MaRS Discovery District receiving an award for "Creative City" where it has space for cutting-edge research and helps to turn into commercial opportunities.

In today's information-rich environment, companies can no longer afford to rely entirely on their own ideas to advance their business, nor can they restrict their innovations to a single path to market. As a result, says Harvard Business School professor Henry W. Chesbrough, the traditional model for innovation--which has been largely internally focused, closed off from outside ideas and technologies--is becoming obsolete. Emerging in its place is a new paradigm, open innovation, which strategically leverages internal and external sources of ideas and takes them to market through multiple paths. Arguing that companies in all industries must transform the way they commercialize knowledge, Chesbrough convincingly shows how open innovation can unlock the latent economic value in a company''s ideas and technologies.

Canada needs to do more to encourage the private sector to commercialize discoveries working in partnership with academia and governments. Mention of the successful partnership i.e. MaRS.

Karl Martin turned a pure research project into a commercial venture set to change how we interact with the emerging "surveillance society" by improving personal privacy. U of T's Innovations and Partnerships Office and the MaRS Centre came on board to help these researchers patent their work and attain funding opportunities.

MD-entrepreneur Cal Stiller, noted for advocating commercial development of research, wins Gairdner Award and hall of fame berth. Dr. Calvin Stiller is the Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada.

The Honourable Peter Van Loan, Minister of International Trade, met with senior Swedish government officials and key business leaders to enhance business opportunities between the two countries and promote Canada-EU comprehensive economic and trade agreement negotiations. Minister Van Loan states, "Science and technology cooperation continues to be an important part of our commercial relationship, and we look forward to intensifying our bilateral partnership in this area, including at Canadian institutions such as the MaRS Centre at the University of Toronto, and the University of Calgary."

Hon. John Milloy, Minister of Research and Innovation and Minister of Training, Colleges and Univesities, states "Ontario has big expectations and goals for the life sciences industry and commercialization." MaRS is an innovation centre in Toronto.

Premier Dalton McGuinty designed the trade mission to Israel in part as a means of understanding Israel's success in nurturing innovation and attracting venture capital. Of 38 companies and organizations taking part in Ontario's six-day life sciences trade mission to Israel, only two are from Ottawa, and only one is a local business. MaRS Innovation, an agency devoted to commercializing research from 14 Toronto academic institutions, has strengthened linkages in Toronto.

MaRS Innovation (a sister company of MaRS Discovery District) brokers a deal between scientists at Sunnybrook Health Sciences Centre and Sanofi-Pasteur Canada. The product helps wounds heal more quickly -- potentially benefiting diabetics whose wounds tend to reopen. It's an example of how commercialization of medical technologies is moving from lab to real health outcomes.

As stated in Canadian Manufacturing, "Researchers from the University of Toronto (U of T), the King Abdullah University of Science & Technology (KAUST) and Pennsylvania State University (Penn State) have created the most efficient solar cell ever made based on collodial-quatum-dots...a technology licensing agreement has been signed by U of T and KAUST, brokered by MaRS Innovations (MI), which will will enable the global commercialization of this new technology."